These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 19496935)
21. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. Madureira A; Bergeron A; Lacroix C; Robin M; Rocha V; de Latour RP; Ferry C; Devergie A; Lapalu J; Gluckmana E; Socié G; Ghannoum M; Ribaud P Int J Antimicrob Agents; 2007 Dec; 30(6):551-4. PubMed ID: 18029149 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. MacCallum DM; Whyte JA; Odds FC Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042 [TBL] [Abstract][Full Text] [Related]
23. Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. Al-Tawfiq JA; Al-Abdely HM Med Mycol; 2010 May; 48(3):537-41. PubMed ID: 19886765 [TBL] [Abstract][Full Text] [Related]
24. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Baddley JW; Andes DR; Marr KA; Kauffman CA; Kontoyiannis DP; Ito JI; Schuster MG; Brizendine KD; Patterson TF; Lyon GM; Boeckh M; Oster RA; Chiller T; Pappas PG Med Mycol; 2013 Feb; 51(2):128-35. PubMed ID: 22680976 [TBL] [Abstract][Full Text] [Related]
26. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium. Selleslag D; Vogelaers D; Marbaix S Acta Clin Belg; 2009; 64(5):393-8. PubMed ID: 19999386 [TBL] [Abstract][Full Text] [Related]
27. [Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus]. Domergue V; Orlandini V; Begueret H; Couprie B; Huerre M; Tunon de Lara M; Beylot-Barry M; Doutre MS Ann Dermatol Venereol; 2008 Mar; 135(3):217-21. PubMed ID: 18374855 [TBL] [Abstract][Full Text] [Related]
28. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172 [TBL] [Abstract][Full Text] [Related]
29. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450 [TBL] [Abstract][Full Text] [Related]
31. Disseminated invasive aspergillosis in a patient with acute leukaemia. Gottfredsson M; Steingrímsdóttir H Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060 [TBL] [Abstract][Full Text] [Related]
32. Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases. Huang HD; Li Q; Huang Y; Bai C; Wu N; Wang Q; Yao XP; Chen B Chin Med J (Engl); 2012 Apr; 125(7):1236-41. PubMed ID: 22613594 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species. Zhang M; Su X; Sun WK; Chen F; Xu XY; Shi Y Mycopathologia; 2014 Feb; 177(1-2):11-8. PubMed ID: 24306184 [TBL] [Abstract][Full Text] [Related]
34. [Efficacies and clinical roles of new antifungal agents]. Tokimatsu I; Kadota J Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948 [TBL] [Abstract][Full Text] [Related]
35. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Parize P; Chandesris MO; Lanternier F; Poirée S; Viard JP; Bienvenu B; Mimoun M; Méchai F; Mamzer MF; Herman P; Bougnoux ME; Lecuit M; Lortholary O Antimicrob Agents Chemother; 2009 Mar; 53(3):1048-53. PubMed ID: 19104029 [TBL] [Abstract][Full Text] [Related]
36. [Cardiac invasive aspergillosis in a heart transplant recipient]. Eworo A; Muñoz P; Yáñez JF; Palomo J; Guembe P; Roda J; Valerio M; Guinea J; Bouza E Rev Iberoam Micol; 2011; 28(3):134-8. PubMed ID: 21700234 [TBL] [Abstract][Full Text] [Related]
37. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Levy ER; McCarty JM; Shane AL; Weintrub PS Clin Infect Dis; 2013 Jun; 56(11):1573-8. PubMed ID: 23463636 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis. Fincher T; Fulcher SF Cornea; 2007 Jun; 26(5):618-20. PubMed ID: 17525663 [TBL] [Abstract][Full Text] [Related]
39. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. Sun HL; Zhou X; Shen YF Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183 [No Abstract] [Full Text] [Related]
40. Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Alanio A; Brethon B; Feuilhade de Chauvin M; de Kerviler E; Leblanc T; Lacroix C; Baruchel A; Menotti J Clin Infect Dis; 2008 May; 46(10):e116-8. PubMed ID: 18419477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]